CONSENT OF SMITH ANGLIN & CO.
Published on June 12, 1996
EXHIBIT 23(d)
CONSENT OF INDEPENDENT AUDITORS
The Board of Directors
ACCESS Pharmaceuticals, Inc.
We consent to the use of our report included herein and to the reference to our
Firm under the heading "Experts" in the prospectus.
/s/ Smith Anglin & Co.
--------------------------
Smith Anglin & Co.
Dallas, Texas
June 11, 1996